Senior Convertible Note Purchase Agreement Dated as of April 9, 2020Senior Convertible Note Purchase Agreement • April 9th, 2020 • Scynexis Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 9th, 2020 Company Industry JurisdictionSENIOR CONVERTIBLE NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of April 9, 2020 (the “Closing Date”), among SCYNEXIS, Inc., a Delaware corporation, as Issuer (the “Company”), and Puissance Life Science Opportunities Fund VI (the “Investor”).
Senior Convertible Note Purchase Agreement Dated as of March 7, 2019Senior Convertible Note Purchase Agreement • May 8th, 2019 • Scynexis Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 8th, 2019 Company Industry JurisdictionSENIOR CONVERTIBLE NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of March 7, 2019 (the “Closing Date”), among SCYNEXIS, Inc., a Delaware corporation, as Issuer (the “Company”), and Puissance Life Science Opportunities Fund VI (the “Investor”).
Senior Convertible Note Purchase Agreement Dated as of March 7, 2019Senior Convertible Note Purchase Agreement • March 8th, 2019 • Scynexis Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 8th, 2019 Company Industry JurisdictionSENIOR CONVERTIBLE NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of March 7, 2019 (the “Closing Date”), among SCYNEXIS, Inc., a Delaware corporation, as Issuer (the “Company”), and Puissance Life Science Opportunities Fund VI (the “Investor”).